KALY – Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements
The report speculates a potential KALY price per share of $0.05.
Read More
Category: Featured News
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery
The news covers Innovative Drug-Delivery Systems Benefit Patients and Businesses.
Read More
Lexaria Bioscience Corp. (CSE:Â LXX) (OTCQX:Â LXRP) Featured in NetworkNewsWire Publication Reporting on Momentous Advances in Drug-Delivery Innovation
Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods.
Read More
What is the Seed-to-Sale Certified quality promise?
Aphria holds itself to high quality standards when it comes to the cultivation and production of medical cannabis.
Read More
The Impact of Product Format on Effects
A product that’s inhaled through smoking or vaporizing, will have different effects from a product format that’s ingested, such as cannabis oil products.
Read MoreGET LISTED
